Literature DB >> 16700047

Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor.

Norman E Breslow1, J Bruce Beckwith, Elizabeth J Perlman, Anthony E Reeve.   

Abstract

BACKGROUND: The National Wilms Tumor Study (NWTS) constitutes a unique resource for study of clinical, pathologic, and epidemiologic features of Wilms tumor (WT). PROCEDURE: Data from NWTS-3,4,5 were compiled for 7,455 patients with tumors of favorable (FH) or anaplastic (AH) histology. The associations of birth weight (BW) and age-at-onset with gender, intralobar (ILNR), and perilobar (PLNR) nephrogenic rests, tumor focality, congenital malformation syndromes, and tumor histology were analyzed using descriptive statistics and linear regression.
RESULTS: Mean BWs for male and female patients without PLNR were 3.52 and 3.36 kg, respectively, and for those with PLNR were 0.12 kg and 0.15 kg heavier. Mean age was 45 months for males with no rests whose tumors were unifocal and of triphasic favorable histology. ILNR or multifocality decreased the mean age by 18 and 10 months, respectively, whereas female gender, blastemal/FH or AH increased it by 3, 10, and 16 months. Over 90% of multifocal tumors occurred in the presence of demonstrated ILNR or PLNR or both. The apparent bimodality of the age distributions and later mean ages-at-onset for females with both unifocal and multifocal tumors were explained in part by the relative deficit in females of ILNR versus PLNR-associated tumors.
CONCLUSIONS: These observations support the view that there are multiple pathways to Wilms tumorigenesis. They will facilitate selection of informative subgroups of patients for molecular analysis that may serve to identify the putative pathway for the majority of patients who cannot be classified provisionally on the basis of ILNR or PLNR.

Entities:  

Mesh:

Year:  2006        PMID: 16700047      PMCID: PMC1543666          DOI: 10.1002/pbc.20891

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  24 in total

1.  Wilms' tumor, overgrowth, and fetal growth factors: a hypothesis.

Authors:  A F Olshan
Journal:  Cancer Genet Cytogenet       Date:  1986-04-15

2.  Frequent association of beta-catenin and WT1 mutations in Wilms tumors.

Authors:  S Maiti; R Alam; C I Amos; V Huff
Journal:  Cancer Res       Date:  2000-11-15       Impact factor: 12.701

Review 3.  Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor.

Authors:  J B Beckwith; N B Kiviat; J F Bonadio
Journal:  Pediatr Pathol       Date:  1990

4.  Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study.

Authors:  Suzanne E Little; Sandra P Hanks; Linda King-Underwood; Chris Jones; Elizabeth A Rapley; Nazneen Rahman; Kathy Pritchard-Jones
Journal:  J Clin Oncol       Date:  2004-10-15       Impact factor: 44.544

5.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

6.  Epigenetic differences between Wilms' tumours in white and east-Asian children.

Authors:  Ryuji Fukuzawa; Norman E Breslow; Ian M Morison; Patrick Dwyer; Takeshi Kusafuka; Yasutsugu Kobayashi; David M Becroft; J Bruce Beckwith; Elizabeth J Perlman; Anthony E Reeve
Journal:  Lancet       Date:  2004-02-07       Impact factor: 79.321

7.  Twenty-four new cases of WT1 germline mutations and review of the literature: genotype/phenotype correlations for Wilms tumor development.

Authors:  Brigitte Royer-Pokora; Manfred Beier; Markus Henzler; Rita Alam; Valérie Schumacher; Angela Weirich; Vicki Huff
Journal:  Am J Med Genet A       Date:  2004-06-15       Impact factor: 2.802

8.  Epidemiological features of Wilms' tumor: results of the National Wilms' Tumor Study.

Authors:  N E Breslow; J B Beckwith
Journal:  J Natl Cancer Inst       Date:  1982-03       Impact factor: 13.506

9.  Two molecular subgroups of Wilms' tumors with or without WT1 mutations.

Authors:  Valérie Schumacher; Stefanie Schuhen; Sandra Sonner; Angela Weirich; Ivo Leuschner; Dieter Harms; Jonathan Licht; Stefan Roberts; Brigitte Royer-Pokora
Journal:  Clin Cancer Res       Date:  2003-06       Impact factor: 12.531

10.  International variations in the incidence of childhood renal tumours.

Authors:  C A Stiller; D M Parkin
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

View more
  32 in total

1.  Perilobar nephrogenic rests are nonobligate molecular genetic precursor lesions of insulin-like growth factor-II-associated Wilms tumors.

Authors:  Raisa Vuononvirta; Neil J Sebire; Anthony R Dallosso; Jorge S Reis-Filho; Richard D Williams; Alan Mackay; Kerry Fenwick; Anita Grigoriadis; Alan Ashworth; Kathy Pritchard-Jones; Keith W Brown; Gordan M Vujanic; Chris Jones
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

Review 2.  Wilms' tumour: a complex enigma to decipher.

Authors:  María José Robles-Frías; Michele Biscuola; María Angeles Castilla; María Angeles López-García; Felicia Sánchez-Gallego; José Palacios
Journal:  Clin Transl Oncol       Date:  2008-08       Impact factor: 3.405

Review 3.  Metanephric adenofibroma in a 10-year-old boy: report of a case and review of the literature.

Authors:  Dong-Wei Yao; Feng Qu; Su-Wei Hu; Jin-Yu Zheng; Jin-Mei Wang; Xiang-Yu Zhu; Jie Li; Hong-Qian Guo
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

4.  Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor.

Authors:  Jane Lange; Susan M Peterson; Janice R Takashima; Yevgeny Grigoriev; Michael L Ritchey; Robert C Shamberger; J Bruce Beckwith; Elizabeth Perlman; Daniel M Green; Norman E Breslow
Journal:  J Urol       Date:  2011-06-17       Impact factor: 7.450

5.  Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2.

Authors:  Jesse K Sandberg; Yueh-Yun Chi; Ethan A Smith; Sabah Servaes; Fredric A Hoffer; Elizabeth A Mullen; Elizabeth J Perlman; Brett Tornwall; Peter F Ehrlich; James I Geller; Paul E Grundy; Conrad V Fernandez; Jeffrey S Dome; Geetika Khanna
Journal:  AJR Am J Roentgenol       Date:  2020-03-11       Impact factor: 3.959

6.  A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys-Drash syndrome.

Authors:  Thatiana Evilen da Silva; Mirian Yumie Nishi; Elaine Maria Frade Costa; Regina Matsunaga Martin; Filomena Marino Carvalho; Berenice Bilharinho Mendonca; Sorahia Domenice
Journal:  Pediatr Nephrol       Date:  2011-05-11       Impact factor: 3.714

7.  K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth.

Authors:  Efterpi Dalpa; Victor Gourvas; Nikolaos Soulitzis; Demetrios A Spandidos
Journal:  Med Oncol       Date:  2016-12-09       Impact factor: 3.064

8.  Anthropomorphic measurements and event-free survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group.

Authors:  Conrad V Fernandez; James Anderson; Norman E Breslow; Jeffrey S Dome; P E Grundy; Elizabeth J Perlman; Daniel M Green
Journal:  Pediatr Blood Cancer       Date:  2009-02       Impact factor: 3.167

Review 9.  Innovations in the management of Wilms' tumor.

Authors:  Joseph M Gleason; Armando J Lorenzo; Paul R Bowlin; Martin A Koyle
Journal:  Ther Adv Urol       Date:  2014-08

10.  Perinatal risk factors for Wilms tumor in a Swedish national cohort.

Authors:  Casey Crump; Jan Sundquist; Weiva Sieh; Marilyn A Winkleby; Kristina Sundquist
Journal:  Eur J Epidemiol       Date:  2014-02-08       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.